Stephen J.LurieMD, PhD, Senior EditorIndividualAuthorPhil B.FontanarosaMD, Executive Deputy EditorIndividualAuthor
To the Editor: The article by Dr Sherman and
colleagues1 on the results of the STAT trial
showed an advantage of ancrod given within 3 hours from onset of ischemic
stroke. However, the comments made by these authors about the results of European
Stroke Treatment with Ancrod Trial (ESTAT), an ongoing European trial with
ancrod administered 6 hours after stroke onset, require clarification.
Orgogozo J, Verstraete M, Kay R, Hennerici M, Lenzi G, . Outcomes of Ancrod in Acute Ischemic Stroke. JAMA. 2000;284(15):1926-1927. doi:10.1001/jama.284.15.1921